Notes

Latest data update

15 December 2020

Section

Page updated

Data sources

Interactive data

International comparisons

OECD Health Statistics 2020

COVID-19

Purchase and consumption of other drugs

Ecstasy and Related Drugs Reporting System (EDRS) 2020

COVID-19

Purchase and consumption of alcohol and other drugs

National Wastewater Drug Monitoring Program Report 11 2020

Section 1 – Harm minimisation 

Supply reduction

National Wastewater Drug Monitoring Program Report 11 2020

Section 1 – Harm minimisation

Supply reduction

Illicit Drug Data Report 2018–19

Section 2 – Impacts

Health impacts

National Hospital Morbidity Database 2018–19

Section 2 – Impacts

Health impacts – Mental health conditions 

Health impacts – Injury and hospitalisation

Social impacts – Risky behaviours and criminal activity

Ecstasy and Related Drugs Reporting System (EDRS) 2019

Section 2 – Impacts

Health impacts – Injury and hospitalisation 

National Surveillance System for Alcohol and Other Drug Misuse and Overdose

Section 2 – Impacts

Purchase and consumption of alcohol and other drugs

National Wastewater Drug Monitoring Program Report 11 2020

Section 3 – Drug types

Cannabis – Availability

Meth/amphetamine and other stimulants – Availability

Non-medical use of pharmaceutical drugs - Harms

Illicit opioids, including heroin - Availability

New (and emerging) psychoactive substances – Availability

 

Illicit Drug Data Report 2018–19

Section 3 – Drug types

Cannabis – Availability

Meth/amphetamine and other stimulants – Availability, consumption

New and emerging psychoactive substances – Consumption

Ecstasy and Related Drugs Reporting System (EDRS) 2019

Section 3 – Drug types

Alcohol - Harms

Cannabis – Harms

Meth/amphetamine and other stimulants – Harms

Non-medical use of pharmaceutical drugs - Harms

National Hospital Morbidity Database 2018–19

Section 3 – Drug types

Tobacco - Consumption

Alcohol - Consumption

Cannabis – Consumption

Meth/amphetamine and other stimulants – Consumption

Non-medical use of pharmaceutical drugs – Consumption

Illicit opioids, including heroin – Consumption

New (and emerging) psychoactive substances - Consumption

National Wastewater Drug Monitoring Program Report 11 2020

Section 3 – Drug types

Alcohol - Harms

Cannabis – Harms

Meth/amphetamine and other stimulants – Harms

Non-medical use of pharmaceutical drugs – Harms

Illicit opioids, including heroin - Harms

National Surveillance System for Alcohol and Other Drug Misuse and Overdose

Section 4 – Priority populations

Aboriginal and Torres Strait Islander people – Illicit drugs, Health and harms, Policy context

Aboriginal and Torres Strait Islander Health Performance Framework 2020

Section 4 – Priority populations

People experiencing homelesness

 

Specialist Homelessness Services annual report 2019–20

Section 4 – Priority populations

People in contact with the criminal justice system – Alcohol consumption, Illicit drugs

DUMA 2020

Section 4 – Priority populations

People in contact with the criminal justice system –Illicit drugs

Illicit Drug Data Report 2018–19

Section 4 – Priority populations

People in contact with the criminal justice system –Illicit drugs

Ecstasy and Related Drugs Reporting System (EDRS) 2019

Section 4 – Priority populations

People identifying as lesbian, gay, bisexual, transgender, intersex or queer – Illicit drugs

Australian NSP Survey 2019